The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status

References

1. 1.↵
   1. Stoller JK,
   2. Smith P,
   3. Yang P,
   4. Spray J

   . Physical and social impact of alpha-1 antitrypsin deficiency: Results of a mail survey of the readership of a national newsletter. Cleve Clin J Med 1994;61(6):461–467.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Stoller JK,
   2. Brantly M

   . The challenge of detecting alpha-1 antitrypsin deficiency. COPD 2013;10(Suppl 1):26–34.

   OpenUrlCrossRef
3. 3.
   1. Stoller JK,
   2. Aboussouan LS

   . A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med 2012;185(3):246–259.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Campos MA,
   2. Wanner A,
   3. Zhang G,
   4. Sandhaus RA

   . Trends in the diagnosis of symptomatic patients with alpha-1 antitrypsin deficiency between 1968 and 2003. Chest 2005;128(3):1179–1186.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Köhnlein T,
   2. Janciauskiene S,
   3. Welte T

   . Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency. Ther Adv Respir Dis 2010;4(5):279–287.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Greulich T,
   2. Ottaviani S,
   3. Bals R,
   4. Lepper PM,
   5. Vogelmeier C,
   6. Luisetti M,
   7. Ferrarotti I

   . Alpha-1 antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. Respir Med 2013;107(9):1400–1408.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Stoller JK,
   2. Sandhaus RA,
   3. Turino G,
   4. Dickson R,
   5. Rodgers K,
   6. Strange C

   . Delay in diagnosis of alpha-1 antitrypsin deficiency: A continuing problem. Chest 2005;128(4):1989–1994.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Crystal RG,
   2. Buist AS,
   3. Fallat RJ,
   4. Gadek JE,
   5. Schluchter MD,
   6. Stoller JK,
   7. Turino GM,
   8. Vreim CE,
   9. Wu MC,
   10. Zhang R

   The Alpha-1 antitrypsin Deficiency Registry Study Group, prepared by Crystal RG, Buist AS, Fallat RJ, Gadek JE, Schluchter MD, Stoller JK, Turino GM, Vreim CE, Wu MC, Zhang R. Survival and rate of FEV1 decline in subjects enrolled in the NHLBI Registry of Patients with Severe Deficiency of Alpha-1 antitrypsin. Am J Respir Crit Care Med 1998;158(1):49–59.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Chapman KR,
   2. Burdon JG,
   3. Piitulainen E,
   4. Sandhaus RA,
   5. Seersholm N,
   6. Stocks JM,
   7. et al

   .; RAPID Trial Study Group. Intravenous augmentation treatment and lung density in severe alpha-1 antitrypsin deficiency (RAPID): a randomized, double-blind, placebo-controlled trial. Lancet 2015;386(9991):360–368.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Schoepfer AM,
    2. Dehlavi MA,
    3. Fournier N,
    4. Safroneeva E,
    5. Straumann A,
    6. Pittet V,
    7. et al

    .; IBD Cohort Study Group. Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol 2013;108(11):1744–1753; quiz 1754.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Lipka S,
    2. Kumar A,
    3. Richter JE

    . Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol 2016;50(2):134–140.

    OpenUrl
12. 12.↵
    1. Haroon M,
    2. Gallagher P,
    3. FitzGerald O

    . Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015;74(6):1045–1050.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Seo MR,
    2. Baek HL,
    3. Yoon HH,
    4. Ryu HJ,
    5. Choi HJ,
    6. Baek HJ,
    7. Ko KP

    . Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol 2015;34(8):1397–1405.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Tanash HA,
    2. Nilsson PM,
    3. Nilsson JA,
    4. Piitulainen E

    . Clinical course and prognosis of never-smokers with severe alpha-1 antitrypsin deficiency (PiZZ). Thorax 2008;63(12):1091–1095.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Jones PW,
    2. Quirk FH,
    3. Baveystock CM,
    4. Littlejohns P

    . A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321–1327.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Jones PW,
    2. Harding G,
    3. Berry P,
    4. Wiklund I,
    5. Chen WH,
    6. Kline Leidy N

    . Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34(3):648–654.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Jones PW

    . COPD assessment test – rationale, development, validation and performance. COPD 2013;10(2):269–271.

    OpenUrl
18. 18.↵
    American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168(7):818–900.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Anie KA,
    2. Jones PW,
    3. Hilton SR,
    4. Anderson HR

    . A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol 1996;49(6):653–656.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB

    . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179–187.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Knudson RJ,
    2. Lebowitz MD,
    3. Holberg CJ,
    4. Burrows B

    . Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127(6):725–734.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Sandhaus RA,
    2. Turino G,
    3. Brantly ML,
    4. Campos M,
    5. Cross CE,
    6. Goodman K,
    7. et al

    . The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis 2016;3(3):668–682.

    OpenUrl
23. 23.↵
    1. Marciniuk DD,
    2. Hernandez P,
    3. Balter M,
    4. Bourbeau J,
    5. Chapman KR,
    6. Ford GT

    ; Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2012;19(2):109–116.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Menga G,
    2. Miravitlles M,
    3. Blanco I,
    4. Echazarreta AL,
    5. Rossi SE,
    6. Sorroche PB,
    7. et al

    . Normativas de diagnóstico y tratamiento del déficit de alfa-1 antitripsina Asociación Argentina de Medicina Respiratoria [Guidelines on Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency]. RAMR 2014;1:28–46. Available at http://www.ramr.org/articulos/volumen_14_numero_1/articulos_especiales/articulo_especial_normativas_diagnostico_tratamiento_alfa1.php

    OpenUrl
25. 25.↵
    1. Vidal R,
    2. Blanco I,
    3. Casas F,
    4. Jardí R,
    5. Miravitlles M

    ; Committee on the National Registry of Individuals with Alpha-1 Antitrypsin Deficiency. [Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]. Arch Bronconeumol 2006;42(12):645–659.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Jones PW

    . St. George's Respiratory Questionnaire: MCID. COPD 2005;2(1):75–79.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Kon SS,
    2. Canavan JL,
    3. Jones SE,
    4. Nolan CM,
    5. Clark AL,
    6. Dickson MJ,
    7. et al

    . Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014;2(3):195–203.

    OpenUrl
28. 28.↵
    1. Mayer AS,
    2. Stoller JK,
    3. Bartelson Bartelson B,
    4. James Ruttenber A,
    5. Sandhaus RA,
    6. Newman LS

    . Occupational exposure risks in individuals with PI*Z alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2000;162(2 Pt 1):553–558.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Hatipoğlu U,
    2. Stoller JK

    . Alpha-1 antitrypsin deficiency. Clin Chest Med 2016;37(3):487–504.

    OpenUrl